Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Lois, TAE; Lopez-Polin, A; Norman, FF; Monge-Maillo, B; Lopez-Velez, R; Perez-Molina, JA.

Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain

Travel Medicine and Infectious Disease. 2017; 15: 52-56 Nº de citas: 17 [doi:10.1016/j.tmaid.2016.10.013]

Gallant, J; Moyle, G; Berenguer, J; Shalit, P; Cao, HY; Liu, YP; Myers, J; Rosenblatt, L; Yang, LF; Szwarcberg, J.

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial

CURRENT HIV RESEARCH. 2017; 15(3): 216-224 Nº de citas: 5 [doi:10.2174/1570162X14666161021102728]

Pozniak, A; Flamm, J; Antinori, A; Bloch, M; Ward, D; Berenguer, J; Cote, P; Andreatta, K; Garner, W; Szwarcberg, J; Nguyen-Cleary, T; McColl, DJ; Piontkowsky, D.

Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI

HIV CLINICAL TRIALS. 2017; 18(4): 141-148 Nº de citas: 17 [doi:10.1080/15284336.2017.1338844]

Micozzi, S; Perez-Ezquerra, PR; Morales-Cabeza, C; Diez, C; De Barrio, M.

Stevens Johnson Syndrome versus Jarisch Herxheimer Reaction in an HIV Positive Patient with Secondary Syphilis

Recent Patents on Inflammation & Allergy Drug Discovery. 2017; 11(2): 125-128 [doi:10.2174/1872213X11666171026111648]

de la Calle, GM; Pulido, F; Sanchez-Conde, M; de Quiros, JCLB.

Long-term comparative and prospective cohort study of renal function in patients with HIV infection treated with tenofovir disoproxil fumarate

HIV & AIDS Review. 2017; 16(2): 77-83 Nº de citas: 1 [doi:10.5114/hivar.2017.66859]

Bouteloup, V; Sabin, C; Mocroft, A; Gras, L; Pantazis, N; Le Moing, V; d'Arminio Monforte, A; Mary-Krause, M; Roca, B; Miro, J; Battegay, M; Brockmeyer, N; Berenguer, J; Morlat, P; Obel, N; De Wit, S; Fatkenheuer, G; Zangerle, R; Ghosn, J; Perez-Hoyos, S; Campbell, M; Prins, M; Chene, G; Meyer, L; Dorrucci, M; Torti, C; Thiebaut, R.

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients

HIV MEDICINE. 2017; 18(1): 33-44 Nº de citas: 17 [doi:10.1111/hiv.12389]

Laguno, M; Von Wichmann, MA; Van den Eynde, E; Navarro, J; Cifuentes, C; Murillas, J; Veloso, S; Martinez-Rebollar, M; Guardiola, JM; Jou, A; Gomez-Sirvent, JL; Cervantes, M; Pineda, JA; Lopez-Calvo, S; Carrero, A; Montes, ML; Deig, E; Tapiz, A; Ruiz-Mesa, JD; Cruceta, A; de Lazzari, E; Mallolas, J.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2016; 53: 46-51 Nº de citas: 1 [doi:10.1016/j.ijid.2016.10.028]

Troya, J; Ryan, P; Ribera, E; Podzamczer, D; Hontanon, V; Terron, JA; Boix, V; Moreno, S; Barrufee, P; Castano, M; Carrero, A; Galindo, MJ; Suarez-Lozano, I; Knobel, H; Raffo, M; Solis, J; Yllescas, M; Esteban, H; Gonzalez-Garcia, J; Berenguer, J; Imaz, A.

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

PLoS One. 2016; 11(10): Nº de citas: 7 [doi:10.1371/journal.pone.0164455]

Estrada, V; Monge, S; Gomez-Garre, MD; Sobrino, P; Masia, M; Berenguer, J; Portilla, J; Vilades, C; Martinez, E; Blanco, JR.

Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy

HIV MEDICINE. 2016; 17(9): 653-661 Nº de citas: 23 [doi:10.1111/hiv.12368]

Medrano, LM; Rallon, N; Berenguer, J; Jimenez-Sousa, MA; Soriano, V; Aldamiz-Echevarria, T; Fernandez-Rodriguez, A; Garcia, M; Tejerina, F; Martinez, I; Benito, JM; Resino, S.

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

Journal of Translational Medicine. 2016; 14: Nº de citas: 22 [doi:10.1186/s12967-016-1005-7]

Jimenez-Sousa, MA; Berenguer, J; Rallon, N; Pineda-Tenor, D; Aldamiz-Echevarria, T; Soriano, V; Garcia-Alvarez, M; Vazquez-Moron, S; Restrepo, C; Carrero, A; Benito, JM; Resino, S.

IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

LIVER INTERNATIONAL. 2016; 36(9): 1258-1266 Nº de citas: 9 [doi:10.1111/liv.13079]

Rivero, A; Polo, R; Aldeguer, JL; Lozano, F; Antela, A; Aguirrebengoa, K; Arribas, JR; Asensi, V; Berenguer, J; Blanco, JR; Boix, V; Casado, JL; Clotet, B; Crespo, M; Domingo, P; Duenas, C; Estrada, V; Garcia, F; Gatell, JM; Gomez-Sirvent, JL; Gonzalez-Garcia, J; Gutierrez, F; Iribarren, JA; Knobel, H; Llibre, JM; Losa, JE; Mallolas, J; Marino, A; Miro, JM; Moreno, S; Palacios, R; Pineda, JA; Pulido, F; Ribera, E; Rubio, R; Moreno, JS; Sanz, JS; Tellez, MJ; de la Torre, J; Tuset, M; Molina, JAP.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2016)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2016; 34(7): 439-451 Nº de citas: 12 [doi:10.1016/j.eimc.2016.02.028]

Berenguer, J; Rivero, A; Blasco, AJ; Arribas, JR; Boix, V; Clotet, B; Domingo, P; Gonzalez-Garcia, J; Knobel, H; Lazaro, P; Lopez, JC; Llibre, JM; Lozano, F; Miro, JM; Podzamczer, D; Tuset, M; Gatell, JM.

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2016; 34(6): 361-371 Nº de citas: 8 [doi:10.1016/j.eimc.2015.07.012]

Neukam, K; Espinosa, N; Collado, A; Delgado-Fernandez, M; Jimenez-Aguilar, P; Rivero-Juarez, A; Hontanon-Antonana, V; Gomez-Berrocal, A; Ruiz-Morales, J; Merino, D; Carrero, A; Tellez, F; Rios, MJ; Hernandez-Quero, J; de Lagarde-Sebastian, M; Perez-Camacho, I; Vera-Mendez, F; Macias, J; Pineda, JA.

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

PLoS One. 2016; 11(5): Nº de citas: 8 [doi:10.1371/journal.pone.0155842]

Garcia-Alvarez, M; Berenguer, J; Jimenez-Sousa, MA; Vazquez-Moron, S; Carrero, A; Gutierrez-Rivas, M; Aldamiz-Echevarria, T; Lopez, JC; Garcia-Broncano, P; Resino, S.

Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients

AIDS. 2016; 30(7): 1069-1074 Nº de citas: 7 [doi:10.1097/QAD.0000000000001007]

Pineda-Tenor, D; Jimenez-Sousa, MA; Rallon, N; Berenguer, J; Soriano, V; Aldamiz-Echevarria, T; Garcia-Alvarez, M; Diez, C; Fernandez-Rodriguez, A; Benito, JM; Resino, S.

Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2016; 32(3): 226-231 Nº de citas: 2 [doi:10.1089/aid.2015.0223]

Rallon, N; Mothe, B; de Quiros, JCLB; Plana, M; Ligos, JM; Montoya, M; Munoz-Fernandez, MA; Esteban, M; Garcia, F; Brander, C; Benito, JM.

Balance between activation and regulation of HIV-specific CD8(+) T-cell response after modified vaccinia Ankara B therapeutic vaccination

AIDS. 2016; 30(4): 553-562 Nº de citas: 9 [doi:10.1097/QAD.0000000000000966]

Aldamiz-Echevarria, T; Berenguer, J; Miralles, P; Jimenez-Sousa, MA; Carrero, A; Pineda-Tenor, D; Diez, C; Tejerina, F; Perez-Latorre, L; Bellon, JM; Resino, S.

Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome

PLoS One. 2016; 11(2): Nº de citas: 11 [doi:10.1371/journal.pone.0148537]